advertisement

---

Pharmaceutics 20

Showing records 1 to 20 | Display all abstracts in Pharmaceutics

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Kim M
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Martinez SM
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Zeppieri M; Gagliano C
Pharmaceutics 2025; 17:

---

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Jung MY
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Inda A
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Tognetto D
Pharmaceutics 2025; 17:

---

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee DY
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Ríos MN
Pharmaceutics 2025; 17:

---

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Ahn SM
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Bessone CDV
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Musa M; Rossi FB
Pharmaceutics 2025; 17:

---

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Lee GM
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Bruera Bossio A
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Greggio A
Pharmaceutics 2025; 17:

---

125853 How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
Park CY
Pharmaceutics 2024; 16:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Guido ME
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Gualandi G
Pharmaceutics 2025; 17:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Luna Pinto JD; Allemandi DA
Pharmaceutics 2025; 17:

---

125254 Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma
Galan A; Babighian S
Pharmaceutics 2025; 17:

---

126008 Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
Quinteros DA
Pharmaceutics 2025; 17:

---